Safety of a tetanus-diphtheria-acellular pertussis vaccine when used off-label in an elderly population
HF Tseng, LS Sy, L Qian, SM Marcy… - Clinical infectious …, 2013 - academic.oup.com
Background. Published data on the safety of tetanus-diphtheria-acellular pertussis vaccine
(Tdap) in persons aged≥ 65 years are limited. This study aims to examine a large cohort of …
(Tdap) in persons aged≥ 65 years are limited. This study aims to examine a large cohort of …
Safety review of tetanus toxoid, reduced diphtheria toxoid, acellular pertussis vaccines (Tdap) in adults aged≥ 65 years, Vaccine Adverse Event Reporting System …
P Haber, PL Moro, C Ng, GM Dores, S Perez-Vilar… - Vaccine, 2020 - Elsevier
Abstract Introduction The Advisory Committee on Immunization Practices (ACIP)
recommends vaccination with tetanus toxoid, reduced diphtheria toxoid, and acellular …
recommends vaccination with tetanus toxoid, reduced diphtheria toxoid, and acellular …
Adverse events after tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine administered to adults 65 years of age and older reported to the …
PL Moro, X Yue, P Lewis, P Haber, K Broder - Vaccine, 2011 - Elsevier
BACKGROUND: Tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap)
vaccine was not licensed for use in adults aged≥ 65 years due to lack of sufficient efficacy …
vaccine was not licensed for use in adults aged≥ 65 years due to lack of sufficient efficacy …
The safety of immunizing with tetanus–diphtheria–acellular pertussis vaccine (Tdap) less than 2 years following previous tetanus vaccination: experience during a …
EA Talbot, KH Brown, KB Kirkland, AL Baughman… - Vaccine, 2010 - Elsevier
BACKGROUND: Tdap is recommended for health care personnel (HCP) aged< 65 years
who received tetanus diphtheria or tetanus toxoid immunization (Td/TT)≥ 2 years earlier …
who received tetanus diphtheria or tetanus toxoid immunization (Td/TT)≥ 2 years earlier …
Vaccination of adults 65 years of age and older with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Boostrix®): results of two randomized …
WM Weston, LR Friedland, X Wu, B Howe - Vaccine, 2012 - Elsevier
BACKGROUND: Pertussis can cause significant morbidity in elderly patients, who can also
transmit this disease to infants and young children. There is little data available on the use of …
transmit this disease to infants and young children. There is little data available on the use of …
The burden of pertussis in older adults: what is the role of vaccination? A systematic literature review
W Kandeil, P Atanasov, D Avramioti, J Fu… - Expert review of …, 2019 - Taylor & Francis
Introduction: Pertussis (whooping cough) is a vaccine-preventable disease; however,
neither natural-nor vaccine-induced protection is life-long. Although generally not severe in …
neither natural-nor vaccine-induced protection is life-long. Although generally not severe in …
Estimating the effectiveness of tetanus-diphtheria-acellular pertussis vaccine (Tdap) for preventing pertussis: evidence of rapidly waning immunity and difference in …
R Koepke, JC Eickhoff, RA Ayele… - The Journal of …, 2014 - academic.oup.com
Background. We estimated the vaccine effectiveness (VE) of tetanus-diphtheria-acellular
pertussis vaccine (Tdap) for preventing pertussis among adolescents during a statewide …
pertussis vaccine (Tdap) for preventing pertussis among adolescents during a statewide …
Immunogenicity and safety of one dose of diphtheria, tetanus, acellular pertussis and poliomyelitis vaccine (Repevax®) followed by two doses of diphtheria, tetanus …
R Dominicus, F Galtier, P Richard, M Baudin - Vaccine, 2014 - Elsevier
Introduction The immunogenicity and safety of one dose of Tdap-IPV (tetanus, diphtheria,
acellular pertussis and inactivated poliomyelitis vaccine) and two doses of Td-IPV (tetanus …
acellular pertussis and inactivated poliomyelitis vaccine) and two doses of Td-IPV (tetanus …
Barriers to early uptake of tetanus, diphtheria and acellular pertussis vaccine (Tdap) among adults—United States, 2005–2007
BL Miller, K Kretsinger, GL Euler, PJ Lu, F Ahmed - Vaccine, 2011 - Elsevier
Background The tetanus, diphtheria and acellular pertussis vaccine (Tdap) was
recommended by the Advisory Committee on Immunization Practices (ACIP) for US adults in …
recommended by the Advisory Committee on Immunization Practices (ACIP) for US adults in …
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine in Adults Aged 65 Years and Older …
Centers for Disease Control and … - MMWR: Morbidity & …, 2012 - search.ebscohost.com
Abstract Since 2005, the Advisory Committee on Immunization Practices (ACIP) has
recommended a tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) …
recommended a tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) …